Sunday, October 30. 2011
        
                
        
                        
                                                    
            
            
                 Dear colleagues,
 
They just keep coming, almost daily, pre-emptively spamming all the people we had been hoping to win over to Open Access. 
 
Not only is it regrettable that OA is so unthinkingly identified in most people's minds with  gold OA publishing in general, but this growing spate of relentless fool's-gold junk-OA spamming in particular is now coalescing with that misconception -- and at the same time more and more universities and funders are reaching into their scarce funds to pay for this kind of thing,  thinking this is the way to provide OA. 
 
(Meanwhile,  green OA mandates, the real solution, are still hovering at about 200 out of about 10,000 (2%!) -- and mostly needlessly watered-down mandates. I wish I could figure out a way to turn this liability -- fool's-gold spam and scam -- into an asset for spreading green mandates, but I'm afraid that even  Richard Poynder's critical articles are being perceived mostly as critical of OA itself rather than just of fool's-gold OA.)
 
The real culprits are not the ones trying to make a buck out of this current spike in pay-to-publish-or-perish/gold-fever co-morbidity, but the researchers themselves, who can't put 2+2 together and provide green OA on their own, cost-free; and their institutions and funders, who can't put 2+2 together and mandate that they do it. 
 
Instead of thinking, it's easier to shell out for fool's gold...
 
Richard's exposés are helpful, but I think they are not enough to open people's eyes. 
 
So all we can do is hope that the spamming itself will become so blatant and intrusive that it will wake people up to the fact that this is not the way to provide OA...
 
Stevan
 
PS Not only do I not work on anything faintly resembling "proteomics/bioinformatics" but I have no "relationship with OMICS Group" (except possibly prior complaints about spam)! These spam disclaimers are a lark. They seem to be using professional spam services that try to appear respectable.  From: "JPB"<editor.jpb@omicsgroup.co> 
Date: October 28, 2011 4:29:28 AM EDT 
To: "Stevan Harnad"  
Subject: Invitation for Special Issue: Journal of Proteomics & Bioinformatics 
Reply-To: editor.jpb@omicsgroup.co 
 
You are receiving this email because of your relationship with OMICS Group. Please reconfirm your interest in receiving email from us. If you do not wish to receive any more emails, you can unsubscribe here 
  
Journal of Proteomics & Bioinformatics - Open Access 
                                      
                        Dear Dr. Stevan Harnad,  
                         
                        We are glad to announce the success of Journal of Proteomics & Bioinformatics  (JPB) an Open Access platform for proteomics, bioinformatics research and updates.  
                         
                        To provide a rapid turn-around time regarding reviewing, publishing and to disseminate the articles freely for research, teaching and reference purposes we are releasing following special issues.  
  
                                Upcoming Special Issues Handling Editor(s) 
                               
Domain-Domain Interactions Dr. Chittibabu (Babu) Guda, University of Nebraska Medical Center, USA 
Microarray Proteomics Dr. Qiangwei Xia, University of Wisconsin-Madison, USA 
Canonical approach: Moleculomics Dr. Lifeng Peng, Victoria University, China 
Shifts and deepens : Biomarkers Dr. Kazuyuki Nakamura, Yamaguchi University, Japan 
Membrane Protein Transporters Dr. Mobeen Raja, University of Alberta, Canada 
Structural and Functional Biology Dr. Viola Calabró, University of Naples "Federico II", ITALY 
HLA-based vaccines Dr. Mario Hugo Genero, Universidad Austral, Republica Argentina 
Insulin Signaling & Insulin Resistance Dr. Zhengping Yi, Arizona State University, USA 
Proteomics for Cancer chemoprevention Dr. Imtiaz Siddiqui, University of Wisconsin, USA 
Membrane Proteomics Dr. Yurong Lai, Groton Laboratory, Pfizer, Inc, UK 
                        We would like to request a contribution from you for any of these special issues or regular issues of the Journal to improve the Open Access motto in this field.  
                         
                        For more details PS : http://www.omicsonline.com/SpecialissueJPB.php  
                         
                        Why to submit and benefits : http://www.omicsonline.org/special-features.php  
                         
                        Submit your article online at : http://www.editorialmanager.com/proteomics/  
                                                                                                            (Or)  
                        As e-mail attachment to the Editorial Office :editor.jpb@omicsgroup.co  
                         
                        We shall look forward to hear from you.  
                         
                        Sincerely,  
                         
                        Editors, Journal of Proteomics & Bioinformatics  
                         
                        Dr. Chittibabu (Babu) Guda, University of Nebraska Medical Center, USA  
                        Dr. Qiangwei Xia, University of Wisconsin-Madison, USA  
                        Dr. Lifeng Peng, Victoria University, China  
                        Dr. Kazuyuki Nakamura, Yamaguchi University, Japan  
                        Dr. Mobeen Raja, University of Alberta, Canada  
                        Dr. Viola Calabró, University of Naples "Federico II", ITALY  
                        Dr. Mario Hugo Genero, Universidad Austral, Republica Argentina  
                        Dr. Zhengping Yi, Arizona State University, USA  
                        Dr. Imtiaz Siddiqui, University of Wisconsin, USA  
                        Dr. Yurong Lai, Groton Laboratory, Pfizer, Inc, UK  
                         
                        Editorial office  
                        OMICS Publishing Group  
                        5716 Corsa Ave., Suite 110  
                        Westlake, Los Angeles  
                        CA 91362-7354, USA  
                        E-mail:editor.jpb@omicsgroup.co  
                        Ph: +1-650-268-9744  
                        Fax: +1-650-618-1414  
                        Toll free: +1-800-216-6499  
                         
                        Unique features:  
                        • User friendly/feasible website-translation of your paper to 50 world’s leading languages  
                        • Audio version of published paper  
                        • Digital articles to share and explore  
                        • 200 Open Access Journals  
                        • 10,000 Editorial team  
                        • 21 days rapid review process  
                        • Indexing at PubMed (partial), Scopus, Chemical Abstracts, Scholar, DOAJ, EBSCO, Index Copernicus and Google Scholar etc  
                        • Sharing Option: Social Networking Enabled  
                        • Authors, Reviewers and Editors rewarded with online Scientific Credits  
                        
        This message was sent... by editor.jpb@omicsgroup.co 
        Unsubscribe from all mailings  
         
        Manage Subscription | Forward Email | Report Abuse
   
      
             
            
            
            
         
        
        
                    
            
            
            
            
            
        
                    
        
        
             
    
    
 |